Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Premier Foods hikes divi 62% as branded volumes drive strong FY growth

(Sharecast News) - Shares in Premier Foods rose on Thursday after the food manufacturer hiked its dividend significantly and reported strong branded volume growth and trading profits ahead of expectations for the year ended 29 March. The company, known for its Mr Kipling, Ambrosia and Angel Delight brands, reported revenues of £1.15bn for the year, up 3.5% over the previous year, with branded revenues rising 5.2% to £1.01bn.

Headline trading profit rose 6% year-on-year to £187.8m; in January, the company had guided to profits at the upper end of the £180.1m-186.4m forecast range by analysts.

Chief executive Alex Whitehouse said the company's "premiumisation strategy" was paying off, "reflecting the trend for consumers to trade up and treat themselves to ranges such as our Ambrosia Deluxe and Mr Kipling Signature Bites, both of which delivered very strong revenue growth this year".

Meanwhile, revenues in new categories surged 46%, led by Ambrosia porridge pots, while the company also grew its overseas businesses by 23%.

Premier Foods proposed a final dividend of 2.8p per share, up 62% from the year before, as part of the redeployment of funds to shareholders following the removal of the dividend match to its pension scheme. Previously, the dividend match mechanism paid a proportion of cash to the pension scheme whenever a cash dividend was paid to shareholders.

"We are one step further towards the full resolution of the pension scheme," Whitehouse said, which should be achieved by the end of 2026.

The stock was 1.2% higher at 202p by 0822 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.